Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases.
Tamas PongraczMaaike BiewengaAnna Eva Charlotte StoelingaMarco René BladergroenSimone NicolardiLeendert Adrianus TrouwDana L E VergoossenNoortje de HaanBart van HoekPublished in: Journal of translational medicine (2024)
Compared to other liver diseases, AIH shows distinctively high A4GS levels in plasma, with potential implications on glycoprotein function and clearance. Plasma-derived glycosylation has potential to be used as a diagnostic marker for AIH in the future. This may alleviate the need for a liver biopsy at diagnosis. Glycosidic changes should be investigated further in longitudinal studies and may be used for diagnostic and monitoring purposes in the future.